MedTrace Logo

The Effect of Intravenous Nalbuphine on PONV With Intrathecal Morphine in Abdominoplasty.

NCT03786562 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 80

Last updated 2020-03-16

No results posted yet for this study

Summary

How effectively intravenous nalbuphine can reduce the incidence of PONV after intrathecal administration of morphine in abdominoplastic surgery.

Conditions

  • Abdominal Obesity

Interventions

DRUG

Intrathecal Morphine

Group 1

DRUG

Intrathecal Morphine + Intravenous Nalbuphine

Group 2

Sponsors & Collaborators

  • Assiut University

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
20 Years
Max Age
50 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-03-08
Primary Completion
2020-03-31
Completion
2020-09-30

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03786562 on ClinicalTrials.gov